Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe-Elie Salem

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
British Journal of Clinical Pharmacology|December 18, 2021
Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and womenChristian Funck-Brentano, Joe-Elie Salem
Biomolecules|September 28, 2023
Pharmacological and Nutritional Modulation of Metabolome and Metagenome in Cardiometabolic DisordersAnna Maria Witkowska, Joe-Elie Salem
The Journal of Invasive Cardiology|December 11, 2012
Transfemoral aortic valve implantation in a renal transplant patient with a Dacron aorto-bi-iliac bypassJoe-Elie Salem, Jean-François Paul, Christophe Caussin
Leukemia|November 19, 2022
Managing Waldenström's macroglobulinemia with BTK inhibitorsChristian Buske, Wojciech Jurczak, Joe-Elie Salem, et al.
World Journal of Clinical Cases|January 2, 2018
Sickle-cell and alpha-thalassemia traits resulting in non-atherosclerotic myocardial infarction: Beyond coincidence?Lee S Nguyen, Alban Redheuil, Olivier Mangin, et al.
Pharmacology & Therapeutics|July 26, 2016
Influence of steroid hormones on ventricular repolarizationJoe-Elie Salem, Joachim Alexandre, Anne Bachelot, et al.
Current Cardiology Reports|July 12, 2023
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related MyocarditisAlexi Vasbinder, Anis Ismail, Joe-Elie Salem, et al.
Frontiers in Pharmacology|February 22, 2021
Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature ReviewLee S Nguyen, Lisa Raia, Bénédicte Lebrun-Vignes, et al.
Therapie|March 15, 2020
Uses of pharmacovigilance databases: An overviewKévin Bihan, Bénédicte Lebrun-Vignes, Christian Funck-Brentano, et al.
BMC Cancer|November 23, 2020
The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitorsZahra Karimian, Sandra Mavoungou, Joe-Elie Salem, et al.
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
British Journal of Clinical Pharmacology|December 18, 2021
Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and womenChristian Funck-Brentano, Joe-Elie Salem
Biomolecules|September 28, 2023
Pharmacological and Nutritional Modulation of Metabolome and Metagenome in Cardiometabolic DisordersAnna Maria Witkowska, Joe-Elie Salem
The Journal of Invasive Cardiology|December 11, 2012
Transfemoral aortic valve implantation in a renal transplant patient with a Dacron aorto-bi-iliac bypassJoe-Elie Salem, Jean-François Paul, Christophe Caussin
Leukemia|November 19, 2022
Managing Waldenström's macroglobulinemia with BTK inhibitorsChristian Buske, Wojciech Jurczak, Joe-Elie Salem, et al.
World Journal of Clinical Cases|January 2, 2018
Sickle-cell and alpha-thalassemia traits resulting in non-atherosclerotic myocardial infarction: Beyond coincidence?Lee S Nguyen, Alban Redheuil, Olivier Mangin, et al.
Pharmacology & Therapeutics|July 26, 2016
Influence of steroid hormones on ventricular repolarizationJoe-Elie Salem, Joachim Alexandre, Anne Bachelot, et al.
Current Cardiology Reports|July 12, 2023
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related MyocarditisAlexi Vasbinder, Anis Ismail, Joe-Elie Salem, et al.
Frontiers in Pharmacology|February 22, 2021
Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature ReviewLee S Nguyen, Lisa Raia, Bénédicte Lebrun-Vignes, et al.
Therapie|March 15, 2020
Uses of pharmacovigilance databases: An overviewKévin Bihan, Bénédicte Lebrun-Vignes, Christian Funck-Brentano, et al.
BMC Cancer|November 23, 2020
The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitorsZahra Karimian, Sandra Mavoungou, Joe-Elie Salem, et al.
Pageof 20